Stifel Nicolaus analyst Annabel Samimy reiterated a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report) today and set a price target of $45.00. The company’s shares closed yesterday at ...
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) on November 8 and set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback